Zak Mir talks to Dr Arron Tolley, CEO Aptamer Group, as the developer of novel Optimer® binders to enable innovation in the life sciences industry, announced that a genetic medicines customer has selected to progress to the final commercial development phase for Optimer delivery vehicles.
Author
